Data supporting the angiotensin II activates MEL18 to deSUMOylate HSF2 for hypertension-related heart failure

Chih Yang Huang, Chia Hua Kuo, Pei Ying Pai, Tsung Jung Ho, Yueh Min Lin, Ray Jade Chen, Fuu Jen Tsai, V. Vijaya Padma, Wei Wen Kuo, Chih Yang Huang

研究成果: 雜誌貢獻文章

2 引文 斯高帕斯(Scopus)

摘要

In association with the published article “Inhibition of HSF2 SUMOylation via MEL18 upregulates IGF-IIR and leads to hypertension-induced cardiac hypertrophy” (Huang et al., 2017) [1], this data article contains information about deSUMOylation of HSF2 on lysine 82 on angiotensin II (ANG II) -induced cardiac hypertrophy, which is mediated by MEL18. Isolated adult human whole heart tissue showed MEL18-mediated HSF2-IGF-IIR pathway is upregulated in hypertension human heart, compared to health human heart.
原文英語
頁(從 - 到)521-526
頁數6
期刊Data in Brief
16
DOIs
出版狀態已發佈 - 二月 1 2018

    指紋

ASJC Scopus subject areas

  • General

引用此

Huang, C. Y., Kuo, C. H., Pai, P. Y., Ho, T. J., Lin, Y. M., Chen, R. J., Tsai, F. J., Vijaya Padma, V., Kuo, W. W., & Huang, C. Y. (2018). Data supporting the angiotensin II activates MEL18 to deSUMOylate HSF2 for hypertension-related heart failure. Data in Brief, 16, 521-526. https://doi.org/10.1016/j.dib.2017.11.040